Equities

Farmacias Benavides SAB de CV

Farmacias Benavides SAB de CV

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (MXN)19.49
  • Today's Change0.000 / 0.00%
  • Shares traded176.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 21 2024 15:02 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in MXNIncome statement in MXNView more

Year on year Farmacias Benavides SAB de CV grew revenues 6.22% from 16.22bn to 17.23bn while net income improved 66.09% from 127.30m to 211.43m.
Gross margin31.03%
Net profit margin1.19%
Operating margin4.89%
Return on assets2.54%
Return on equity40.39%
Return on investment5.81%
More ▼

Cash flow in MXNView more

In 2023, Farmacias Benavides SAB de CV increased its cash reserves by 10.20%, or 64.81m. The company earned 1.44bn from its operations for a Cash Flow Margin of 8.34%. In addition the company used 214.75m on investing activities and also paid 1.16bn in financing cash flows.
Cash flow per share3.06
Price/Cash flow per share6.13
Book value per share1.57
Tangible book value per share1.48
More ▼

Balance sheet in MXNView more

Farmacias Benavides SAB de CV has a Debt to Total Capital ratio of 80.72%, a lower figure than the previous year's 440.13%.
Current ratio0.9472
Quick ratio0.337
Total debt/total equity4.19
Total debt/total capital0.8072
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.